Journal Information
Original Article
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
Diferencia sex-específica para el cáncer de pulmón de células pequeñas del avance de la inmunoterapia
You Moa,b, Yiwei Qinc, Jian Shangguanb, Duncan Weia, Meng Wub, Dawei Chenb,1,
, Jinming Yua,b,1,
Corresponding author
Corresponding author
a Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
b Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
c Cheeloo College of Medicine, Shandong University
Highlights
- •
Provided the first evidence of a significant difference in immunotherapy advance among sex for SCLC based population mortality. Patient with SCLC in women benefit significantly.